Actojenic Tablet 35mg | Agents Affecting Bone Metabolism | Pharmaceuticals | Products

繁

简

Scroll

Products

Actojenic Tablet 35mg

Code:

DRPS0067A

Active Ingredient:

Risedronate Sodium 35mg

Description:

Film coated light orange oval tablet embossed "RSN" one side and "Jl" on other side

Regulatory Class:

P1S1S3
Prescription Drug

HK-62644

Use and Administration
Use and Administration

Use and Administration

Adult : PO Paget's disease of bone 30 mg once daily for 2 mth, repeat if necessary after 2 mth interval. Treatment and prophylaxis of postmenopausal or corticosteroid-induced osteoporosis 5 mg/day. Increase bone mass in men w/ osteoporosis 35 mg once wkly.

Oral
Treatment and prophylaxis of postmenopausal or corticosteroid-induced osteoporosis
Adult: 5 mg daily. Alternatively, for postmenopausal osteoporosis, 35 mg once wkly, or 75 mg on 2 consecutive days of each mth, or 150 mg once mthly.

Oral
Paget's disease of bone
Adult: 30 mg once daily for 2 mth, may repeat if necessary after 2 mth interval.

Oral
Increase bone mass in men with osteoporosis
Adult: 35 mg once wkly.

繁

简